More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Li... ( Less Than 20 Percent of Patients ...)

HOME >> BIOLOGY >> TECHNOLOGY

More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy

Date:4/7/2008

Less Than 20 Percent of Patients Diagnosed with the Disease Receive Pharmacotherapy Within a Year of Their Diagnosis, According to a New Report

From Decision Resources

WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim's Flomax, also marketed as Astellas's Harnal in Japan, is the physician's drug of choice for newly diagnosed benign prostatic hyperplasia patients. Garnering more patient share than any other alpha blocker in first- and second-line therapy for benign prostatic hyperplasia, Flomax holds a 55.2 percent first-line patient share, compared with 12.4 percent for Sanofi-Aventis's Uroxatral, 4.8 percent for doxazosin (Pfizer's Cardura/Cardura XL, generics), and 4.3 percent for terazosin (Abbott's Hytrin, generics).

"Flomax stands out among alpha blockers thanks to its lower propensity to induce orthostatic hypotension, despite evidence of a high incidence of retrograde ejaculation and higher cost relative to generic agents in this class", said Nathan Calloway, analyst at Decision Resources. "However, rather than calling attention to Flomax's side-effect/safety profile, the highest proportion of urologists we surveyed (83 percent) rank familiarity with the drug as an important reason to choose Flomax over Uroxatral, whereas the largest percentage of primary care physicians (66 percent) believe that Flomax's reimbursement and formulary position is a key advantage over Uroxatral's."

The report entitled Treatment Algorithms in Benign Prostatic Hyperplasia also finds that slightly less than one-fifth (18.9 percent) of newly diagnosed benign prostatic hyperplasia patients receive pharmacological treatment within one year of their initial diagnosis. Primary care physicians and urologists surveyed suggest that patient reluctance to take drugs that are associated with sid
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
5. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
8. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
9. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
10. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
11. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain

Post Your Comments:

(Date:12/16/2009)... A has been found to be effectinve in improving yelds of ... ... Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for ... by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... HSP-A has been found to be especially effective in improving yields ...

(Date:12/15/2009)... of three Department of Energy (DOE) bio-energy research centers, ... its valuable intellectual property. , ... ... -- Surety, LLC , the leading provider of ... the Joint BioEnergy Institute (JBEI), one of three Department ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com announces ... available in its catalogue: ,, ... Market Forecasts to 2015, Pipeline Analysis and ... ,, Summary ... research "The Future of Orphan Diseases Therapeutics ...

(Date:12/15/2009)... Force Microscopy (AFM) have been developed and are opening up ... interface. The NeedleProbes’ cylindrical geometry enables researchers to measure ... - all in a single force distance curve. , ... ... constant diameter NeedleProbes are enabling unique measurements at ...

[0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM

... at the University of California, Berkeley, have devised a ... thought possible, potentially opening doors to new technology in ... computers. , Optics researchers succeeded previously in passing light ... than the width of a human hair. A group ...

... Shandong, China, July 30 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, ... one of the leading plasma-based pharmaceutical companies in ... effective July,24, 2008, it has appointed Mr. Sean ... serve as independent members of its Board of ...

... Pharmaceuticals,Inc. (Nasdaq: ANDS ), a clinical-stage biopharmaceutical company ... the areas of,hepatitis C and oncology, today reported its ... 30, 2008., "The first half of 2008 has ... Ph.D., President and CEO. "Through the focused,efforts of our ...

Other Biology Technology:New technique to compress light could open doors for optical communications 2 New technique to compress light could open doors for optical communications 3 China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 2 China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 3 China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 4 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 2 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 3 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 4 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 5 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 6 Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 7

New technique to compress light could open doors for optical communications China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights

(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...

(Date:12/13/2009)... genetic variants that are associated with the health of ... of 96 scientists from 63 centres in Europe and ... lung diseases. , The new findings provide hope for ... Disease (COPD) and asthma. In the past it has ... pathways that affect the health of the lung are ...

(Date:12/11/2009)... GETTYSBURG, PAAs consumer demand for premium fruit increases, ... fruit to market. And to boost their bottom ... that can increase fruit quality while reducing labor ... by growers to produce larger, healthier fruit, is ... a significant impact on fruit production overhead, and, ...

Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2 Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3 New genes for lung disease discovered 2 Horizontal string trimmer reduces labor costs, increases peach size 2 AMDL Inc Introduces New Brand Name for Its DR 70 28FDP 29 In Vitro Diagnostic Cancer Test 51075 1 AMDL Inc Introduces New Brand Name for Its DR 70 28FDP 29 In Vitro Diagnostic Cancer Test 51075 2 AMDL Inc Introduces New Brand Name for Its DR 70 28FDP 29 In Vitro Diagnostic Cancer Test 51075 3 AMDL Inc Introduces New Brand Name for Its DR 70 28FDP 29 In Vitro Diagnostic Cancer Test 51075 4 McCallan and Excerpta Medica Launch MED SELECT Program at HCEA 51071 1 Do bilingual persons have distinct language areas in the brain 3F 51067 1 Do bilingual persons have distinct language areas in the brain 3F 51067 2

[0] Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops [0] New genes for lung disease discovered [0] Horizontal string trimmer reduces labor costs, increases peach size

... writes, "the net effect of [the current system] is that ... safe at the time of marketing, while [adverse] events occurring ... In the May 3 issue of the Journal of the ... Public Health and Preventive Medicine and Chair of the Department ...

... or smell, receptors unique to each nerve cell detect the ... process the message to understand what we are smelling or ... it must use many different receptors to sense and interpret ... environments changes in molecular concentrations as small as 0.1 percent, ...

... at UT Southwestern Medical Center have found that an internal ... cell's response to external signals. , Cilia perform many functions ... make fertilization possible, line the nose to pick up odors, ... such a range of abilities, cilia serve as both motors ...

Other Biology News:How the US drug safety system should be changed 2 Researchers discover how bacteria sense their environments 2 'Cellular antennae' on algae give clues to how human cells receive signals 2

How the US drug safety system should be changed Researchers discover how bacteria sense their environments 'Cellular antennae' on algae give clues to how human cells receive signals

Modified and insect cell culture tested....

Bethyl Laboratories Epitope Retrieval Buffer-Reduced pH will unmask antigenic sites from formaldehyde fixation and allow for subsequent immunostaining. Shelf-Life: 1 year from date of receipt...

Mycoplasma and virus tested...

Edited by Benjamin Lewin (1997) • This book gives an integrated account of the structure and function of genes in both prokaryotic organisms and is thoroughly up to date with the latest thinking...

Biology Products:

Schneider's Drosophila Medium (1X) liquid from Invitrogen Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories GIBCO Newborn Calf Serum; Heat-Inactivated from Invitrogen Genes VI from Promega

More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Li...( Less Than 20 Percent of Patients ...)